Geriatrics
Treatment of small cell lung cancer in the elderly evaluated
Published in Cancer Weekly, September 6th, 2005
According to recent research published in the journal Oncologist, "SCLC accounts for approximately 20% of lung carcinomas. Chemotherapy is the cornerstone of treatment for SCLC."
"In limited disease, the median survival time is about 12-16 months, with a 4%-5% long-term survival rate; in extensive disease the median survival time is 7-11 months. More than 50% of lung cancer patients are diagnosed when they are over the age of 65, and about 30% are over 70. Elderly patients tolerate chemotherapy poorly compared with their younger counterparts, because of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-09-06)
More Articles from Cancer Weekly
- Head & Neck Cancer
Increased mtDNA content in saliva associated with head and neck cancer - Lymphoma
Lack of SmIg light chain expression by B-cells did not always indicate lymphoma - Patient Consultation
Physician sitting v. standing during inpatient oncology consultations compared - Prostate Cancer
Sun exposure and VDR gene polymorphisms linked to risk of prostate cancer - Skin Cancer
Perception of importance of skin cancer assessed - Acute Myeloid Leukemia
AML bearing cytoplasmic nucleophosmin showed distinct gene expression profile - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
